Tens of millions of dollars are being invested by nonprofit patient groups, including the Leukemia & Lymphoma Society, the Multiple Myeloma Research Foundation and the Michael J. Fox Foundation, to create genetic databases in a push to support clinical studies and accelerate drug development. Drugmakers and scholars can analyze genetic mutations using material from these databases, which are created to gather DNA and other data from patients with hard-to-treat diseases. With the aid of these databases, patients familiar with their own genetic mutations can find information about clinical studies.
Published in Brief: